Australia markets open in 5 hours 1 minute

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1250-0.0150 (-10.71%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
102.934
102.934
-
-
-
Gross profit
102.934
102.934
-
-
-
Operating expenses
Research development
5,727
5,727
10,293
6,571
13,699
Selling general and administrative
3,038
3,038
3,556
2,244
8,252
Total operating expenses
12,899
12,899
15,941
10,267
24,259
Operating income or loss
-12,796
-12,796
-15,941
-10,267
-24,259
Interest expense
81.736
81.736
37.44
55.941
50.982
Total other income/expenses net
3,658
3,658
2,770
6,885
7,399
Income before tax
-9,154
-9,154
-13,171
-3,334
-16,731
Income tax expense
0
0
0
0
0
Income from continuing operations
-9,154
-9,154
-13,171
-3,334
-16,731
Net income
-9,154
-9,154
-13,171
-3,334
-16,731
Net income available to common shareholders
-9,154
-9,154
-13,171
-3,334
-16,731
Basic EPS
-
-
-0.01
-0.00
-0.02
Diluted EPS
-
-
-0.01
-0.00
-0.02
Basic average shares
-
-
973,142
972,935
936,371
Diluted average shares
-
-
973,142
972,935
936,371